Hottest Stocks
(Over $10)		 Hottest Stocks
($2-$10)		 Biggest Losers
(Over $10)		 Biggest Losers
($2-$10)		 Hottest
Industries		 Hottest
Sectors		 EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Roche Holding AG (RHHBY : OTC)
 
 • Company Description   
Basel, Switzerland-based Roche Holding Ltd. is a leading health care company focused on developing and commercializing innovative diagnostic and therapeutic products and services, which enable early detection and prevention of diseases as well as their treatment and monitoring. The company conducts its operations through two segments ' Pharmaceuticals and Diagnostics.Pharmaceuticals: Key focus areas in this segment include Oncology, Virology, Inflammation, Metabolism and Neuroscience. Diagnostics: The Diagnostics Division operates in four segments ' Roche Professional Diagnostics, Roche Diabetes Care, Roche Molecular Diagnostics, and Roche Tissue Diagnostics. In September 2014, Roche acquired InterMune for $8.3 billion and added Esbriet to its portfolio. During the first quarter of 2018, Roche acquired Flatiron Health and Ignyta, Inc.

Number of Employees: 103,249

 
 • Price / Volume Information   
Yesterday's Closing Price: $39.35 Daily Weekly Monthly
20 Day Moving Average: 2,189,605 shares
Shares Outstanding: 6,377.94 (millions)
Market Capitalization: $250,971.75 (millions)
Beta: 0.46
52 Week High: $44.31
52 Week Low: $30.06
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 2.82% -4.89%
12 Week -4.14% 0.29%
Year To Date 12.81% 13.54%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
GRENZACHERSTRASSE 124
-
BASEL,V8 CH-4070
CHE		 ph: 41-61-688-1111
fax: 41-0-61-691-9391		 investor.relations@roche.com http://www.roche.com
 
 • General Corporate Information   
Officers
Thomas Schinecker - Chief Executive Officer
Severin Schwan - Chairman
Andre Hoffmann - Vice-Chairman
Alan Hippe - Chief Financial Officer
Patrick Frost - Director

Peer Information
Roche Holding AG (AGN.)
Roche Holding AG (NVS)
Roche Holding AG (NVO)
Roche Holding AG (LLY)
Roche Holding AG (RHHBY)
Roche Holding AG (JNJ)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: Large Cap Pharma
Sector: Medical
CUSIP: 771195104
SIC: 2834
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: -
Next Expected EPS Date: -
Share - Related Items
Shares Outstanding: 6,377.94
Most Recent Split Date: 2.00 (2.00:1)
Beta: 0.46
Market Capitalization: $250,971.75 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 2.22%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.87
Current Fiscal Year EPS Consensus Estimate: $2.93 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 5.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: 5.38% Last Dividend Paid: 03/28/2025 - $0.86
Next EPS Report Date: -  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 13.42
Trailing 12 Months: -
PEG Ratio: 2.49
Price Ratios
Price/Book: 6.11
Price/Cash Flow: 11.94
Price / Sales: -
EPS Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -%
Sales Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -%
ROE
03/31/25 - -
12/31/24 - -
09/30/24 - -
ROA
03/31/25 - -
12/31/24 - -
09/30/24 - -
Current Ratio
03/31/25 - -
12/31/24 - 1.48
09/30/24 - -
Quick Ratio
03/31/25 - -
12/31/24 - 1.20
09/30/24 - -
Operating Margin
03/31/25 - -
12/31/24 - -
09/30/24 - -
Net Margin
03/31/25 - -
12/31/24 - -
09/30/24 - -
Pre-Tax Margin
03/31/25 - -
12/31/24 - 18.90
09/30/24 - -
Book Value
03/31/25 - -
12/31/24 - 6.44
09/30/24 - -
Inventory Turnover
03/31/25 - -
12/31/24 - 2.12
09/30/24 - -
Debt-to-Equity
03/31/25 - -
12/31/24 - 0.85
09/30/24 - -
Debt-to-Capital
03/31/25 - -
12/31/24 - 45.93
09/30/24 - -
 

Powered by Zacks Investment Research ©